Maniglid

Roman name

Maniglide

The composition and the form of

1 tablet contains glibenklamida 5 mg; in vials of 120 pcs. , in a cardboard bundle one umbrella; and banks, dark glass on the 50, 100 and 120 pc. , in a cardboard bundle one bank; or plastic containers on the 100, 120 and 150 pc. , in a cardboard coffee container; or contour acheikova package 10 and 20 pc. ; or contour acheikova packing 10 pcs. or 20 pcs. , in a cardboard unit 2 and 5 packages or 1 and 2 packages respectively.

Of drugs

Gipoglikemicescoe, gipolipidemicescoe. Derived sulfonylureas II generation. It stimulates the secretion of insulin secretion beta-kletkami pancreas.

Indications

Diabetes mellitus type 2, with poor diet.

Pregnancy and lactation

Contraindicated. At the time of treatment should stop breastfeeding.

Contraindications

Hypersensitivity, diabetes mellitus type 1 diabetic ketoacidosis, precoma, coma, decompensation diabetes with infectious diseases, injuries, burns, operational interventions, serious violations of the kidneys and liver, pregnancy, breast-feeding.

Side-Effects

Allergic reactions, nausea, diarrhoea, holetaz violation of the liver, headache, dizziness, fatigue, the blood (up to development pancitopenia) photosensitization.

Patient interaction

Gipoglikemicescoe effect increases with the same application with hloramfenikolom, flukonazolom, sulfanilamidnami drugs (including both ko-trimoksazolom) NPVS, coumarin derivatives, geparinom, lipid control, MAO inhibitors, captoprilom, englaprilom, zimetidine, ranitidine, doksepinom, fenfluraminom, metildofa, nortriptilinom. Weakened, and the simultaneous use of barbiturates, rifampitina, tiazidnykh dioretikov, simpatomimetikov, hlorpromazina, glucocorticoids, isoniazid, estrogen, oral contraceptives, fenitoina, hormones thyroid, diazoksida, azetazolamida, indometacin, saluretikov. Do the pills funds. Beta-adrenoblokatora may mask symptoms gipoglikemii.

Precautions

Admission alcohol can provoke gipoglikemia.

Dosing and Administration

The inside is not liquid, a small amount of liquid for 20 to 30 minutes before delivery, the initial dose of 2.5 mg 1-3 times a day, if necessary dose gradually increased at 2.5 mg / week until the compensation Carbohydrate exchange. Maintaining daily intake, 5-10 mg, the maximum is 15 mg. For older patients initial dose of 1 mg / sut.

Storage conditions

table. : List B. In dry the dark place at a temperature of no higher than 25 ° C

Shelf life

table. : 2 grams.

Directory → Metaboliki → Gipoglikemicakie synthetic and other means → Maniglid